Share this article Share this article ResearchAndMarkets.com's offering. In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Single-use Bioprocessing Market Report The global single-use bioprocessing market by revenue is expected to grow at a CAGR of 17% during the period 2021-2026. The outbreak of the COVID-19 pandemic has boosted the demand for single-use bioprocessing (SUB) technology. The ongoing robust R&D activities and clinical studies on the Covid-19 vaccine are encouraging many stakeholders to use SUB technology. Modalities such as covid-19 vaccine requirement, cell and gene therapies, and monoclonal antibodies are likely to influence the single-use bioprocessing market growth. The majority of biomanufacturing companies rely on advanced technology such as single-use systems to develop the vaccine.t.